Freedman, M. S., Gnanapavan, S., Booth, R. A., Calabresi, P. A., Khalil, M., Kuhle, J., . . . Olsson, T. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. Elsevier.
Chicago Style (17th ed.) CitationFreedman, Mark S., Sharmilee Gnanapavan, Ronald A. Booth, Peter A. Calabresi, Michael Khalil, Jens Kuhle, Jan Lycke, and Tomas Olsson. Guidance for Use of Neurofilament Light Chain as a Cerebrospinal Fluid and Blood Biomarker in Multiple Sclerosis Management. Elsevier, 2024.
MLA (9th ed.) CitationFreedman, Mark S., et al. Guidance for Use of Neurofilament Light Chain as a Cerebrospinal Fluid and Blood Biomarker in Multiple Sclerosis Management. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.